MRNA - Moderna, Inc. So'nggi Yangiliklar | Finranks

12.05.2026

Moderna Recognized by TIME as One of the World's Most Impactful Companies

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies.

12.05.2026

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

12.05.2026

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

Drug development has always been a slow business. A single medicine can take 10 to 15 years and cost billions before it reaches a patient.

12.05.2026

Moderna's Revenues See Strong International Momentum in Q1 Earnings

MRNA's Q1 revenues soar 260% on strong international vaccine sales, while cost cuts and new EU approvals support its broader growth strategy.

12.05.2026

Hantavirus outbreak: these 3 stocks are poised to rip higher

The World Health Organization's recent report of a Hantavirus cluster aboard a cruise ship departing Argentina has refocused global market attention on zoonotic respiratory pathogens. Three confirmed fatalities and a widening caseload linked to the South Atlantic itinerary have forced an urgent global response to intercept a pathogen characterized by high lethality and rapid pulmonary onset.

12.05.2026

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

Moderna's stock is rallying on hopes it could develop a hantavirus vaccine.

11.05.2026

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

The public is growing increasingly concerned about the possibility that a hantavirus outbreak on a cruise could spark a new pandemic.

Videolar

13.02.2026

Neutral

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

04.02.2026

Positive

CANCER BREAKTHROUGH: Moderna, Merck report cancer discovery

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
MRNA	Barclays	Equal Weight	undefined >> $25	January 28th 2026
MRNA	UBS	Neutral	undefined >> $34	January 7th 2026
MRNA	Jefferies	Hold	undefined >> $30	December 12th 2025
MRNA	Citigroup	Neutral	undefined >> $40	March 13th 2025

Press-relizlar

12.05.2026

Moderna Recognized by TIME as One of the World's Most Impactful Companies

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies.

Moderna, Inc. (MRNA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Moderna, Inc. (MRNA)

Moderna Recognized by TIME as One of the World's Most Impactful Companies

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

Moderna's Revenues See Strong International Momentum in Q1 Earnings

Hantavirus outbreak: these 3 stocks are poised to rip higher

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.